Discover the newest research about AI innovations in π Allergy & Immunology.
Emerging peptide technologies revolutionize medicine, food, and cosmetics. AI accelerates discovery, enhancing stability and efficacy. ππ½οΈπ
Immunomodulatory therapy for non-infectious uveitis: addressing gaps, optimizing strategies, and future AI advancements. π§ ποΈ
Coreline Soft secures AI imaging contracts with NHS and Boehringer Ingelheim, enhancing medical image analysis in healthcare. π₯π
Childhood asthma prediction model: 4,338 cases analyzed, AUC 0.853, key predictors include cough, wheezing, and specific IgE levels. π¬οΈπ
WellTheory secures $5 million for AI tools in autoimmune care. New features enhance personalized support for patients. π€π°
A recent study developed an LSTM model to predict allergic rhinitis outpatient visits, enhancing treatment and prevention strategies. πΏπ
Google’s new AI models aim to enhance drug discovery and improve health information access. π§¬π
Aneurin Bevan University Health Board adopts Better ePMA system for safer medication management. π₯π Enhanced efficiency for patients and clinicians.
Women entrepreneurs excelled at the UK Women in Innovation Awards, showcasing innovative health tech solutions. ππ‘
AI enhances prediction of autoimmune disease progression, improving early diagnosis and treatment options. ππ€
